IL178300A0 - Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease - Google Patents
Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery diseaseInfo
- Publication number
- IL178300A0 IL178300A0 IL178300A IL17830006A IL178300A0 IL 178300 A0 IL178300 A0 IL 178300A0 IL 178300 A IL178300 A IL 178300A IL 17830006 A IL17830006 A IL 17830006A IL 178300 A0 IL178300 A0 IL 178300A0
- Authority
- IL
- Israel
- Prior art keywords
- depression
- patients
- prevention
- treatment
- fatty acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04101578 | 2004-04-16 | ||
PCT/EP2005/004031 WO2005110393A1 (en) | 2004-04-16 | 2005-04-15 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
Publications (1)
Publication Number | Publication Date |
---|---|
IL178300A0 true IL178300A0 (en) | 2007-02-11 |
Family
ID=34928968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL178300A IL178300A0 (en) | 2004-04-16 | 2006-09-26 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1765319A1 (en) |
JP (1) | JP2007532605A (en) |
CN (1) | CN1942180A (en) |
AU (1) | AU2005244483B2 (en) |
BR (1) | BRPI0509878A (en) |
CA (1) | CA2504280A1 (en) |
IL (1) | IL178300A0 (en) |
MX (1) | MX291518B (en) |
RU (1) | RU2387448C2 (en) |
UA (1) | UA94693C2 (en) |
WO (1) | WO2005110393A1 (en) |
ZA (1) | ZA200607794B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2421909A (en) * | 2004-12-23 | 2006-07-12 | Laxdale Ltd | Pharmaceutical compositions comprising EPA and methods of use |
ITMI20100961A1 (en) * | 2010-05-27 | 2011-11-28 | Erredue Spa | MIXTURES RICH IN OMEGA-3 FATTY ACIDS, THEIR COMPOSITIONS AND THEIR PREPARATION PROCESS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7222598A (en) * | 1997-04-29 | 1998-11-24 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
WO2002096408A1 (en) * | 2001-05-30 | 2002-12-05 | Laxdale Limited | Coenzyme q and eicosapentaenoic acid (epa) |
-
2005
- 2005-04-15 MX MXPA06011940 patent/MX291518B/en active IP Right Grant
- 2005-04-15 ZA ZA200607794A patent/ZA200607794B/en unknown
- 2005-04-15 CN CNA2005800114285A patent/CN1942180A/en active Pending
- 2005-04-15 BR BRPI0509878-5A patent/BRPI0509878A/en not_active IP Right Cessation
- 2005-04-15 RU RU2006140277/14A patent/RU2387448C2/en not_active IP Right Cessation
- 2005-04-15 UA UAA200611798A patent/UA94693C2/en unknown
- 2005-04-15 CA CA002504280A patent/CA2504280A1/en not_active Abandoned
- 2005-04-15 WO PCT/EP2005/004031 patent/WO2005110393A1/en active Application Filing
- 2005-04-15 EP EP05779398A patent/EP1765319A1/en not_active Withdrawn
- 2005-04-15 AU AU2005244483A patent/AU2005244483B2/en not_active Ceased
- 2005-04-15 JP JP2007507767A patent/JP2007532605A/en active Pending
-
2006
- 2006-09-26 IL IL178300A patent/IL178300A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA06011940A (en) | 2006-12-15 |
CN1942180A (en) | 2007-04-04 |
EP1765319A1 (en) | 2007-03-28 |
AU2005244483A1 (en) | 2005-11-24 |
RU2387448C2 (en) | 2010-04-27 |
JP2007532605A (en) | 2007-11-15 |
WO2005110393A1 (en) | 2005-11-24 |
MX291518B (en) | 2011-10-31 |
UA94693C2 (en) | 2011-06-10 |
CA2504280A1 (en) | 2005-10-16 |
RU2006140277A (en) | 2008-05-27 |
ZA200607794B (en) | 2008-05-28 |
AU2005244483B2 (en) | 2011-06-09 |
BRPI0509878A (en) | 2007-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009003921A (en) | Omega-3 fatty acids and dyslipidemic agent for reduction of apo-b levels. | |
PL1641918T3 (en) | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system | |
AU2002367535A8 (en) | Diagnosis and treatment of vascular disease | |
AU2002323258A1 (en) | Diagnosis and treatment of vascular disease | |
EP1817050A4 (en) | Diagnosis and treatment of alzheimer's disease | |
NO20033304L (en) | Essential N-3 fatty acids in cardiac insufficiency and heart failure therapy | |
IL181234A0 (en) | Mixture of phytosterol ester(s) and 1,3-diglycerides(s) for use in the treatment of medical conditions | |
HUP0700151A2 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
ZA200900334B (en) | DHA esters and use thereof in treatment and prevention of cardiovascular disease | |
EP1750734A4 (en) | Method of preparation and use of fibrinolytic enzymes in the treatment of disease | |
IL176027A0 (en) | Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure | |
EP1773882A4 (en) | Diagnosis and treatment of siglec-6 associated diseases | |
IL179560A0 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
AU2003291536A1 (en) | Method for the diagnosis and treatment of vascular disease | |
AU2002326813A1 (en) | Diagnosis and treatment of vascular disease | |
EP1664775A4 (en) | Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it | |
IL178300A0 (en) | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease | |
ZA200610297B (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
AU2003233681A8 (en) | Diagnosis and treatment of human dormancy syndrome | |
PL371251A1 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
AU2002341880A1 (en) | Diagnosis and treatment of vascular disease | |
AU2002341604A1 (en) | Diagnosis and treatment of vascular disease | |
AU2003298768A8 (en) | Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases | |
EP1589980A4 (en) | Methods of diagnosis and treatment of interstitial lung disease | |
WO2001091785A3 (en) | Use of hyaluronidase for preventing and treating cardio vascular diseases |